InstalabLoading...
InstalabLoading...
Your adrenal glands produce more of this hormone than almost any other steroid in your body, yet it almost never appears on a routine blood draw. That is unfortunate, because it tracks two things at once: how much reserve your adrenals still have, and how much wear and tear your body has taken on as you age.
Knowing your number gives you a window into stress physiology, hormone aging, and adrenal function that cortisol alone cannot show. Lower levels are tied to higher risk of dying from heart disease in older men, more frailty, and the early stages of adrenal disorders that often go undetected for years.
DHEA-S (dehydroepiandrosterone sulfate) is the storage form of DHEA, a steroid hormone produced mainly by the outer layer of your adrenal glands. It circulates at far higher concentrations than most other hormones and lasts much longer in the bloodstream, which is why it makes a more stable read on adrenal function than DHEA itself.
Your body converts DHEA-S into testosterone and estrogen in tissues that need them, including bone, brain, skin, and reproductive organs. It also acts as a counterweight to cortisol, the main stress hormone. When cortisol stays high and DHEA-S stays low, the resulting imbalance is one of the clearest biological fingerprints of chronic stress.
Levels follow a sharp life-course pattern. They rise around age six to eight, peak between roughly 20 and 25, then decline by about 10 percent per decade. By age 70, most people have lost 70 to 80 percent of their peak. This decline is one reason DHEA-S is sometimes called a marker of biological aging.
Some of the strongest evidence for testing DHEA-S comes from long-running studies that tracked older adults for years. In a 27-year follow-up of community men, those with baseline DHEA-S of 200 micrograms per deciliter or higher lived significantly longer than those with levels at or below 129, independent of age, blood pressure, and blood sugar.
In another large study of elderly Swedish men, each 100 microgram per deciliter increase in DHEA-S was tied to roughly 36 percent lower all-cause mortality and 48 percent lower cardiovascular mortality after adjusting for other risk factors. A meta-analysis pooling 18 studies in people with existing cardiovascular disease found that those in the lowest DHEA-S category had about 47 percent higher all-cause mortality and 58 percent higher fatal cardiovascular event risk than those in higher categories.
The signal is most consistent in men. In middle-aged men, DHEA-S in the lowest quartile (below about 160 micrograms per deciliter) predicted higher rates of new heart disease over nine years even after accounting for traditional risk factors. In type 2 diabetic men, low DHEA-S was significantly tied to coronary heart disease in nearly 1,000 participants.
Atrial fibrillation, the most common abnormal heart rhythm, also tracks with DHEA-S. A meta-analysis of circulating sex hormones found that men in the highest DHEA-S category had about 27 percent lower risk of atrial fibrillation than men in the lowest, while testosterone and estradiol showed no clear connection.
Frailty in older adults follows a similar pattern. In nearly 1,900 older Japanese community-dwellers, those in the highest sex-specific tertile of DHEA-S had roughly 50 percent lower odds of overall frailty and mobility-related frailty compared with those in the lowest tertile. The mean DHEA-S in the lowest tertile was 46.8 micrograms per deciliter; in the highest, 158.0.
DHEA-S is one of the most useful single tests for picking up subtle adrenal problems. In adults with an adrenal mass found incidentally on imaging, a low DHEA-S can signal autonomous cortisol secretion, a condition where the adrenal gland makes too much cortisol on its own.
Using an age- and sex-adjusted ratio at or below 1.12, one large study found DHEA-S to be more than 99 percent sensitive and about 92 percent specific for subclinical hypercortisolism. A simple cutoff below 60 micrograms per deciliter caught about 76 out of 100 cases with about 81 percent specificity in another prospective cohort. This makes DHEA-S a fast, single-sample alternative to more involved testing.
The reverse is also true. A normal age- and sex-adjusted DHEA-S essentially rules out central adrenal insufficiency, the condition where the brain signal that tells your adrenals to make hormones (called ACTH, short for adrenocorticotropic hormone) is failing. In patients with pituitary tumors, this single test had near-perfect accuracy in younger patients.
In women with polycystic ovary syndrome (PCOS), DHEA-S helps identify how much of the androgen excess is coming from the adrenal gland rather than the ovary. Elevated DHEA-S is more common in non-classic PCOS phenotypes, and very high levels can also signal rarer adrenal causes of androgen excess.
DHEA-S is a second-line test for PCOS diagnosis, with lower accuracy than total or free testosterone. Pooled diagnostic performance is about 75 percent sensitivity and 67 percent specificity. It earns its place when testosterone-based measures are normal but androgen-driven symptoms persist, or when severe or unusual hyperandrogenism warrants ruling out adrenal pathology.
One large mortality study found a J-shaped relationship: both very low and very high DHEA-S were linked to increased mortality. In disabled older women, both extremes carried higher death risk than middle-range levels. This is not contradictory. DHEA-S behaves like a marker of biological balance rather than a simple "more is better" number. Very low values reflect exhausted adrenal reserve. Very high values can reflect adrenal pathology, including tumors and congenital adrenal hyperplasia. The healthiest patterns sit in the age- and sex-appropriate range, neither at the floor nor at the ceiling.
Reference ranges for DHEA-S vary substantially by lab, assay, age, and sex. The values below come from a Roche electrochemiluminescent immunoassay study of healthy women aged 20 to 45. They are illustrative orientation, not a target. Your lab will likely report different numbers, possibly in different units.
| Age (women) | Reference Interval (µmol/L) | What It Suggests |
|---|---|---|
| 20 to 25 | 3.65 to 12.76 | Peak adult range |
| 25 to 35 | 2.97 to 11.50 | Typical young adult range |
| 35 to 45 | 2.30 to 9.83 | Beginning of age-related decline |
Source: Bokulić et al., Roche Cobas ECLIA reference interval study in 4,020 women.
Compare your results within the same lab over time. Different platforms produce meaningfully different numbers, even when both are correctly calibrated. Men typically run higher than women at every age.
Several long-term studies have proposed cutoffs based on health outcomes rather than reference labs. In men, levels of 200 micrograms per deciliter or higher were tied to longer survival, while levels at or below 129 predicted shorter survival. In middle-aged men, the lowest quartile (below about 160 micrograms per deciliter) predicted future heart disease. These are observational thresholds, not consensus targets, but they help put your number in clinical context.
DHEA-S declines steadily with age, so a single number tells you less than a trajectory. Get a baseline test, then retest in 3 to 6 months if you make significant changes (sleep, stress management, exercise, supplementation), and at least annually thereafter to watch for steeper-than-expected decline. In one cohort, steep decline or unusually wide variability over time predicted higher mortality more than a single baseline reading did. The trend is the signal.
If your DHEA-S is unusually low for your age and sex, retest after a few weeks (not during illness or after surgery), and pair it with a morning cortisol and ACTH to assess adrenal axis function. Persistently low values warrant an endocrinology workup, especially if you have an adrenal mass on imaging, a known pituitary issue, or symptoms of adrenal insufficiency such as fatigue, low blood pressure, or hyperpigmentation.
If your DHEA-S is unusually high, the workup centers on identifying the source. Combine it with total and free testosterone, androstenedione, and 17-hydroxyprogesterone to evaluate for adrenal hyperandrogenism, congenital adrenal hyperplasia, or, less commonly, an adrenal tumor. Endocrinology referral is appropriate when levels are markedly elevated or accompanied by virilization.
If your number is simply at the lower end of normal for your age and you feel well, this is more useful as a longevity-tracking metric. Get a follow-up reading, watch the trend, and pair the data with cortisol and a basic metabolic panel to put it in context.
Evidence-backed interventions that affect your Salivary DHEA-S level
DHEA-S is best interpreted alongside these tests.